All data are based on the daily closing price as of April 1, 2025
t

Towa Pharmaceutical

4553.TSE
17.97 USD
-0.25
-1.37%

Overview

Last close
17.97 usd
Market cap
884.56M usd
52 week high
21.55 usd
52 week low
15.68 usd
Target price
25.8 usd

Valuation

P/E
6.8885
Forward P/E
16.7785
Price/Sales
0.5368
Price/Book Value
0.7803
Enterprise Value
2.18B usd
EV/Revenue
1.2872
EV/EBITDA
10.7148

Key financials

Revenue TTM
1.69B usd
Gross Profit TTM
613.05M usd
EBITDA TTM
277.31M usd
Earnings per Share
2.62 usd
Dividend
0.4 usd
Total assets
2.94B usd
Net debt
1.24B usd

About

Towa Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells ethical drugs, active pharmaceutical ingredients, and intermediates in Japan. The company provides its products in the therapeutic areas of digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products. It also offers IT service related to healthcare; and disease risk testing services. In addition, the company is involved with research and development of diagnostic drugs; and planning, development and OEM manufacturing of health food, pharmaceuticals, general food and other products. The company was founded in 1951 and is headquartered in Osaka, Japan.
  • Symbol
    4553.TSE
  • Exchange
    TSE
  • Isin
    JP3623150004
  • Country
    Japan
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
  • Headquarter
    Osaka
  • Web site
    https://www.towayakuhin.co.jp
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top